Looking for Clinical Notes & EndoAI for Doctors? Visit Notes in Endocrinology →

Insulin pumps and automated insulin delivery: are they right for you?

Medically reviewed by Dr. Om J Lakhani on 18 Oct 2026 · Updated 18 Oct 2026

Short answer

An insulin pump is a small device that delivers insulin continuously through a tiny tube or patch under the skin, replacing multiple daily injections. Automated insulin delivery, sometimes called a hybrid closed loop, links the pump to a CGM sensor so the pump adjusts insulin by itself every few minutes, which improves time in range and reduces low sugars. These systems are available in India, mainly for type 1 diabetes, but they are expensive and work best with good training and a diabetes team.

For people with type 1 diabetes, insulin pumps are one of the biggest advances of the last two decades. Newer systems that link a pump with a sensor can now adjust insulin automatically, a step towards what is often called an “artificial pancreas”. They are not a cure and they still need your attention, but they can take a lot of the daily burden off you and your family.

What is an insulin pump?

An insulin pump is a small, phone-sized device that holds a reservoir of rapid-acting insulin. It delivers insulin through a thin tube and a tiny soft cannula under the skin, usually changed every two to three days. Some pumps are “patch” pumps that stick directly to the skin without a tube.

A pump gives insulin in two ways:

  • Basal insulin, a small amount delivered continuously through the day and night, programmed by your diabetes team.
  • Bolus insulin, extra insulin you ask the pump to give for meals or to correct a high sugar. The pump’s calculator suggests the amount based on settings your team sets.

What is automated insulin delivery?

In automated insulin delivery (AID), also called a hybrid closed loop, the pump is connected to a CGM sensor. Every few minutes, a computer program in the pump reads the sensor and adjusts the basal insulin up or down. It can pause insulin before a low and, in advanced systems, give small automatic correction amounts when sugar rises.

It is called “hybrid” because you still need to tell the system when you eat and roughly how much carbohydrate the meal contains. Fully automatic systems that also handle meals by themselves are still being developed.

In trials, AID improved time in range and lowered both HbA1c and low sugars compared with a sensor and pump used without automation. The American Diabetes Association’s 2026 standards describe AID as the preferred insulin delivery option for people with type 1 diabetes, and for other people on intensive insulin, when it is suitable and accessible.

Who benefits most?

  • people with type 1 diabetes, children and adults. Read type 1 diabetes in adults.
  • people with frequent or severe low sugars, or who do not feel their lows
  • people whose sugars swing widely despite careful injections
  • women with type 1 diabetes planning a pregnancy, under specialist care
  • some people with type 2 diabetes who need several insulin injections a day

A pump suits people who are willing to check their sensor, learn carbohydrate counting, and keep in touch with their diabetes team. It is not the right choice for everyone, and injections with a CGM remain an excellent option.

What is available in India?

This section reflects what we could verify as of October 2026. Models and prices change often.

Medtronic launched its MiniMed 780G advanced hybrid closed-loop system in India in March 2022 for people with type 1 diabetes aged 7 to 80 years, and Indian centres have published their experience with it. Older pumps without automation are also used. Some international systems available elsewhere have not been launched in India. You may also read online about open-source “do-it-yourself” closed-loop systems built by patient communities. These are not regulator-approved products, so discuss them with your diabetes team before considering one.

An automated pump in India typically costs several lakh rupees upfront, plus ongoing costs for sensors, infusion sets and reservoirs. Insurance cover is limited. Some families find that the improvement in safety and quality of life justifies the expense, but this is a personal decision. Ask your diabetes team for current costs and any company support programmes.

What training and support do I need?

Before starting a pump you will usually learn:

  • carbohydrate counting for Indian meals
  • how to change infusion sets and sensors
  • what to do when the pump alarms or a set blocks
  • how to manage exercise, illness and travel
  • how to switch back to injections if the pump fails

Your team will set and adjust the pump’s settings and review your data regularly. Never change pump settings without guidance.

What are the risks?

The biggest risk is ketoacidosis. A pump uses only rapid-acting insulin, so if the tube kinks, the cannula comes out or the pump stops, insulin delivery stops and sugar can rise within hours. Always carry backup supplies, including insulin pens or syringes and a ketone meter, as advised by your team. Other issues include site infections, skin reactions, and the cost of supplies. Insulin in the pump also needs protection from heat. Read storing insulin in Indian heat.

What should I ask my doctor?

  • Would a pump or automated system help me more than injections and a CGM?
  • What training and follow-up does your clinic offer?
  • What is the full yearly cost, including supplies?
  • What is my backup plan if the pump fails?

To find out whether a pump suits you, book a consultation.

When to see an endocrinologist

  • High sugar that does not come down after a correction on a pump, especially with nausea, vomiting or belly pain: check ketones and contact your diabetes team immediately, or go to an emergency department
  • Repeated low sugars or a severe low sugar while using a pump
  • A blocked or kinked tube, a wet infusion site or a pump alarm you cannot clear
  • Redness, pain or pus at the infusion site

Chest pain, fainting, severe breathlessness or confusion: call 108 or 112, or go to the nearest emergency department.

Book In-Person / Online Consultation

References

  1. American Diabetes Association. 7. Diabetes technology: Standards of Care in Diabetes 2026. Diabetes Care 2026 (PMID 41358889)
  2. Phillip M et al. Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr Rev 2023 (PMID 36066457)
  3. Brown SA et al. Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med 2019 (PMID 31618560)
  4. Kesavadev J et al. Real-world user and clinician perspective and experience with MiniMed 780G advanced hybrid closed loop system. Diabetes Ther 2023 (PMID 37278948)
  5. BioSpectrum India. Medtronic India launches MiniMed 780G system for diabetes management. 7 March 2022

This page is general health information and does not replace a consultation with your own doctor. Please read our medical disclaimer.

Book In-Person / Online Consultation